F2 and Rare hereditary thrombophilia: Regarding thrombophilia gene mutation detection, 69% of patients had positive thrombophilia gene mutations (52.3% were Factor V Leiden mutation and 16.7% were prothrombin G20210A), while no mutation was detected in 31% of the studied thrombotic group.